• USA Home
  • K1884 - S-(+)-Ketamine hydrochloride

EMAIL THIS PAGE TO A FRIEND
K1884 Sigma

S-(+)-Ketamine hydrochloride

Purchase

Properties

Related Categories Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Bioactive Small Molecules, Cell Biology, Cell Signaling and Neuroscience,
InChI Key   VCMGMSHEPQENPE-ZOWNYOTGSA-N
drug control   USDEA Schedule III; stupéfiant; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain)
originator   Pfizer
storage temp.   2-8°C

Description

Biochem/physiol Actions

Selective NMDA glutamate receptor antagonist.

Features and Benefits

This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Price and Availability


Better Together

Discover your Target

Making Headway
Safety & Documentation

Safety Information

Symbol 
Signal word 
Warning
Hazard statements 
Precautionary statements 
RIDADR 
NONH for all modes of transport
WGK Germany 
3

Documents

Certificate of Analysis

Certificate of Origin

Protocols & Articles
Peer-Reviewed Papers
15

References

Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?